Large-scale testing (Phase 3)Study completedNCT01038661What this trial is testingTax First-line Chemotherapy With Different Doses and Then Maintenance TherapyWho this might be right forLung Neoplasms Sanofi 375
Not applicableEnded earlyNCT00087191What this trial is testingEF5 and Motexafin Lutetium in Detecting Tumor Cells in Patients With Abdominal or Non-Small Cell Lung CancerWho this might be right forAdvanced Adult Primary Liver CancerCarcinoma of the AppendixFallopian Tube Cancer+68 more National Cancer Institute (NCI) 30
Early research (Phase 1)Study completedNCT00020579What this trial is testingMS-275 in Treating Patients With Advanced Solid Tumors or LymphomaWho this might be right forCancer National Institutes of Health Clinical Center (CC) 75
Early research (Phase 1)Study completedNCT01155258What this trial is testingTemsirolimus and Vinorelbine Ditartrate in Treating Patients With Unresectable or Metastatic Solid TumorsWho this might be right forExtensive Stage Small Cell Lung CancerHereditary ParagangliomaMale Breast Cancer+45 more University of Southern California 19
Testing effectiveness (Phase 2)UnknownNCT05745740What this trial is testingRC48-ADC Combined With Pyrotinib For Treatment of Local Advanced or Metastasis NSCLC With HER2 MutationWho this might be right forNon-small Cell Lung Cancer RemeGen Co., Ltd. 26
Testing effectiveness (Phase 2)Active Not RecruitingNCT05888402What this trial is testingInduction Chemotherapy and Toripalimab Followed by Chemoradiotherapy for Large-volume Local Advanced NSCLCWho this might be right forLocal Advanced Non-small Cell Lung Cancer Cancer Institute and Hospital, Chinese Academy of Medical Sciences 50
Testing effectiveness (Phase 2)Study completedNCT00888511What this trial is testingTarceva And Radiotherapy in Locally Advanced Lung Cancer Non-small Cell Lung CancerWho this might be right forNon-small Cell Lung Cancer Olfred Hansen 15
Testing effectiveness (Phase 2)Study completedNCT03673657What this trial is testingStudy of Early Nutritional Intervention During Concurrent Chemoradiotherapy for Local Advanced Non-small Cell Lung CancerWho this might be right forLocal Advanced Non-small Cell Lung Cancer Sun Yat-sen University 67
Testing effectiveness (Phase 2)Ended earlyNCT00642824What this trial is testingA Genetic Substudy Associated With the Avastin (Bevacizumab) Study MO19390 in Patients With Advanced or Recurrent Non-Squamous Cell Lung Cancer.Who this might be right forNon-Squamous Non-Small Cell Lung Cancer Hoffmann-La Roche 3
Testing effectiveness (Phase 2)Looking for participantsNCT06620835What this trial is testingTrial for Local Ablative Treatment (LAT) Optimization in Patients With Advanced Non-Small Cells Lung Cancer (NSCLC) Presenting an Anaplastic Lymphoma Kinase (ALK) Rearrangement Treated by BrigatinibWho this might be right forNSCLC Groupe Francais De Pneumo-Cancerologie 45
Testing effectiveness (Phase 2)Active Not RecruitingNCT06391944What this trial is testingJMT101 Combined With Osimertinib in Patients With Stage Ⅲb-Ⅳ Non-small Cell Lung Cancer (NSCLC) Characterized by Epithermal Growth Factor Receptor (EGFR) Common MutationsWho this might be right forLocal Advanced or Metastatic NSCLCHarboring EGFR Common Mutation Shanghai JMT-Bio Inc. 161
Early research (Phase 1)Active Not RecruitingNCT04013542What this trial is testingIpilimumab and Nivolumab in Combination With Radiation Therapy in Treating Patients With Stage 2-3 Non-small Lung CancerWho this might be right forALK Gene RearrangementEGFR Gene MutationLocally Advanced Lung Non-Small Cell Carcinoma+9 more M.D. Anderson Cancer Center 21
Early research (Phase 1)Active Not RecruitingNCT03707938What this trial is testingLocal Consolidative Therapy and Brigatinib in Treating Patients With Stage IV or Recurrent Non-small Cell Lung CancerWho this might be right forAdvanced Lung CarcinomaALK Gene RearrangementLung Non-Small Cell Carcinoma+4 more M.D. Anderson Cancer Center 35
Testing effectiveness (Phase 2)Looking for participantsNCT07415005What this trial is testingLorlatinib Plus Local Consolidation Therapy In ALK Positive Advanced Non-Small Cell Lung CancerWho this might be right forAdvanced Non-Small Cell Lung Cancer M.D. Anderson Cancer Center 30
Testing effectiveness (Phase 2)Study completedNCT03900117What this trial is testingHypofractionated Radiotherapy Followed by Hypo-boost for Local Advanced NSCLCWho this might be right forNon-small Cell Lung Cancer Sun Yat-sen University 77
Large-scale testing (Phase 3)Not Yet RecruitingNCT06380348What this trial is testingJMT101 in Combination With Osimertinib, Versus Cisplatin-pemetrexed in Participants With Locally Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC) Characterized by Epithermal Growth Factor Receptor (EGFR) Exon 20ins MutationsWho this might be right forLocal Advanced or Metastatic NSCLC Shanghai JMT-Bio Inc. 398
Testing effectiveness (Phase 2)Active Not RecruitingNCT05941897What this trial is testingInvestigate Efficacy and Safety of Ceralasertib Plus Durvalumab in Participants Aged ≥ 18 Years With Advanced or Metastatic Non-small Cell Lung Cancer Whose Disease Progressed on or After Prior Anti-PD-(L)1 Therapy and Platinum-based ChemotherapyWho this might be right forAdvanced or Metastatic NSCLC AstraZeneca 39
Testing effectiveness (Phase 2)UnknownNCT00100256What this trial is testingRhenium Re 188 P2045 in Patients With Lung Cancer Who Have Received or Refused to Receive Prior ChemotherapyWho this might be right forLung NeoplasmsCarcinoma, Non-Small-Cell LungCarcinoma, Small Cell+1 more Andarix Pharmaceuticals 60
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06618391What this trial is testingLocal Injection and Systemic Therapy in the Treatment of NSCLC.Who this might be right forNon-small Cell Lung Cancer Henan Cancer Hospital 84
Large-scale testing (Phase 3)Active Not RecruitingNCT05668988What this trial is testingDZD9008 Versus Platinum-Based Doublet Chemotherapy in Local Advanced or Metastatic Non-small Cell Lung Cancer (WU-KONG28)Who this might be right forNon-small Cell Lung Cancer Dizal Pharmaceuticals 324